Safety, pharmacokinetics, and efficacy of BPI-15086 in patients with EGFR T790M-mutated advanced non-small-cell lung cancer: results from a phase I, single-arm, multicenter study
BPI-15086 在 EGFR T790M 突变型晚期非小细胞肺癌患者中的安全性、药代动力学和疗效:一项 I 期单臂多中心研究的结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100473
Xing, P; Zheng, X; Wang, Y; Chu, T; Wang, S; Jiang, J; Qian, J; Han, X; Ding, L; Wang, Y; Cui, L; Li, H; Li, L; Chen, X; Han, B; Hu, P; Shi, Y